Omalizumab under 12 years old: real-life practice.

نویسندگان

  • H Pite
  • Â Gaspar
  • M Paiva
  • P Leiria-Pinto
چکیده

1. Fiocchi A, Bouygue GR, Restani P, Gaiaschi A, Terracciano L, Martelli A. Anaphylaxis to rice by inhalation. J Allergy Clin Immunol. 2003;111:193--5. 2. Nakase M, Usui Y, Alvarez-Nakase AM, Adachi T, Urisu A, Nakamura R, et al. Cereal allergens: rice-seed allergens with structural similarity to wheat and barley allergens. Allergy. 1998;53 Suppl.:55--7. 3. Asero R, Amato S, Alfieri B, Folloni S, Mistrello G. Rice: another potential cause of food allergy in patients sensitized to lipid transfer protein. Int Arch Allergy Immunol. 2007;143:69--74 [epub 2006 Dec 28]. 4. Enrique E, Ahrazem O, Bartra J, Latorre MD, Castelló JV, de Mateo JA, et al. Lipid transfer protein is involved in rhinoconjunctivitis and asthma produced by rice inhalation. J Allergy Clin Immunol. 2005;116:926--8 [epub 2005 Aug 1]. 5. Kim JH, Kim JE, Choi GS, Hwang EK, An S, Ye YM, et al. A case of occupational rhinitis caused by rice powder in the grain industry. Allergy Asthma Immunol Res. 2010;2:141--3 [epub 2010 Mar 24]. 6. Xu H, Theerakulpisut P, Goulding N, Suphioglu C, Singh MB, Bhalla PL. Cloning, expression and immunological characterization of Ory s 1, the major allergen of rice pollen. Gene. 1995;164: 255--9. 7. Moscato G, Vandenplas O, Van Wijk RG, Malo JL, Perfetti L, Quirce S, et al. EAACI position paper on occupational rhinitis. Respir Res. 2009;10:16. 8. Siracusa A, Desrosiers M, Marabini A. Epidemiology of occupational rinitis: prevalence, aetiology and determinants. Clin Exp Allergy. 2000;30:1519--34. 9. Dordal MT, Lluch-Bernal M, Sánchez MC, Rondón C, Navarro A, Montoro J, et al. Allergen-specific nasal provocation testing: review by the Rhinoconjunctivitis Committee of the Spanish Society of Allergy and Clinical Immunology. J Investig Allergol Clin Immunol. 2011;21:1--12.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)

OBJECTIVE To describe the impact of omalizumab on asthma management in patients treated as part of normal clinical practice in the UK National Health Service (NHS). DESIGN A non-interventional, mixed methodology study, combining retrospective and prospective data collection for 12 months pre-omalizumab and post-omalizumab initiation, respectively. SETTING Data were collected in 22 UK NHS ce...

متن کامل

Profile of patients treated with omalizumab in routine clinical practice in Spain.

BACKGROUND Omalizumab is indicated in patients with severe allergic asthma not controlled by high-dose inhaled glucocorticoids and long-acting beta-agonists. Few data are available on the profile of patients treated with this drug in routine clinical practice in Spain. OBJECTIVE To describe the profile of patients with severe allergic asthma treated with omalizumab and the course of the disea...

متن کامل

Omalizumab in Children with Severe Allergic Asthma: The Italian Real-Life Experience

Background Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic asthma. To date, omalizumab is the only biological drug currently licensed as add-on therapy in children aged > 6 years with moderate-to-severe and severe allergic asthma uncontrolled after treatment with high dose of inhaled corticosteroids plus long-acting inhaled beta2-agonist. The ...

متن کامل

The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.

OBJECTIVE To report the oral corticosteroid-sparing effect of omalizumab in children with severe asthma. DESIGN 16-week therapeutic trial. SETTING Tertiary paediatric asthma clinic. PATIENTS 34 children with severe asthma maintained on oral prednisolone (median age 12 years; 15 children <12 years and 19 children ≥12 years). INTERVENTIONS Fortnightly or monthly subcutaneous injections of...

متن کامل

Benefits of omalizumab on anxiety and depression in patients with severe asthma

Background: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients&rsquo; quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxiety Inventory (STAI). Methods: Anxiety level was determined with STAI, whereas depression level was ...

متن کامل

The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study

BACKGROUND Omalizumab is a non-steroidal medication indicated for the treatment of poorly controlled moderate-to-severe allergic asthmatics. This observational study examines the "real world" effectiveness of omalizumab in this population. METHODS This is a one year open-label observational study that compared clinical outcomes including total oral corticosteroid use, exacerbation history, me...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Allergologia et immunopathologia

دوره 41 2  شماره 

صفحات  -

تاریخ انتشار 2013